A Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration- Resistant Prostate Cancer (mCRPC) Previously Treated with Chemotherapy (KEYNOTE-199)
A Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration- Resistant Prostate Cancer (mCRPC) Previously Treated with Chemotherapy (KEYNOTE-199)
Press Ctrl +⌘ + to increase font size.
Press Ctrl -⌘ - to decrease font size.
Press Ctrl 0⌘ 0 to reset font size.